Ferrand Patrice

Handicare AS manufactures and supplies technical aids for the elderly and disabled people. Its products include wheelchairs, stair lifts, patient handling and bathroom safety products, personal transfer, and automobile adaptation solutions. The company was founded on November 11, 1992 and is headquartered in Moss, Norway.

Laboratoire HRA Pharma SA manufactures and distributes pharmaceutical products. Its products include contraceptive pills such as the pill of two days later and EllaOne. The company was founded by Andre Ulmann in 1996 and is headquartered in Paris, France.

Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium.

Part of Optegra Global Ltd., Optegra International Ltd. functions as an investment holding British company. The company is based in Hildenborough, UK and was founded in 2016.

Heilig Hart Ziekenhuis is a hospital located in Lier, BE. The hospital offers parking, and information about rates and intended users can be found on their website. The hospital staff works to provide care for patients during emergency admissions or day and multi-day stays. Patients can also find information about their stay on the hospital's website. The CEO of the Belgian company is Stefaan Vansteenkiste.

Spineart SA operates as a medical device company. The firm designs, develops and promotes solutions to spine surgeons, operating room teams, and patients. It serves in the area of minimally invasive surgery, motion preservation, fusion, biologics, and fractures treatment. The company was founded by Jérôme Levieux and Stéphane Mugnier in 2005 and is headquartered in Geneva, Switzerland.

Equipe Zorgbedrijven Nederland BV operates a chain of private clinics. Its specialized in hand and wrist, orthopedic, cosmetic, vaginal, and revalidation care. The company was founded by Jak Dekker in 1995 and is headquartered in Eindhoven, the Netherlands.

Optegra UK Ltd. provides ophthalmic services. It offers treatment for cataract, age-related macular degeneration, corneal cross linking and keratoconus and glaucoma. The firm operates hospitals in Birmingham, London, Manchester, Surrey, Solent and Yorkshire. The company was founded in 2006 and is headquartered in London, the United Kingdom.

Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD.

Sofradim Production SAS manufactures medical, surgical and dental equipment. The company is headquartered in Trevoux, France.

Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.

Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.

Part of Novo Nordisk A/S, Novo Nordisk Pharmaceutical Industries, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Clayton, NC.

ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands.

Blaze Bioscience, Inc. develops tumor paint products and Optide-based guided therapeutics for cancer patients. The firm provides BLZ-100. The company was founded by James M. Olson in 2010 and is headquartered in Seattle, WA.

Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands.

ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland.

VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.

Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ.

MAbgène SA is a French company that produces monoclonal antibodies and recombinant proteins through cell culture. The company is based in Alès, France. The company has two CLD platforms available, including a CHO-S platform and their proprietary EMABling® platform. LFB Biotechnologies SASU is a subsidiary of LFB BIOMANUFACTURING, which is ultimately controlled by the Government of France. MAbgène was acquired by LFB Biotechnologies SASU on November 30, 2007 for $4.09 million.

LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France.

HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France.

American Public Health Association provides health care services.